Lim Yinghao retweeted
In patients with severe symptomatic tricuspid regurgitation (TR) and large tricuspid annuli, transcatheter tricuspid valve replacement (TTVR) with the LuX-Valve Plus was associated with high procedural and 30-day clinical success, significant TR reduction, and early functional improvement.
Results from the European TRINITY cohort.
🔗eurointervention.pcronline.c…
#TTVR
@YinghaoLim @vonBardelebenRS @arnaud_sudre @AugustinCoisne @modine_thomas @jgranadacrf @j_hausleiter @nicolasdumonte1 @didier_tchetche @luisnombela @icruzgonzalez @drtpatterson @deharo_pierre
Lim Yinghao retweeted
After TAVI, invasively measured transvalvular gradients—but not echocardiography-derived gradients— were associated with mortality up to 2 years. Echocardiography systematically overestimated gradients, particularly with balloon-expandable valves. Read more in our #EIJBestOf 👇
#CardioTwitter #TAVI
🔗eurointervention.pcronline.c…
@RikAdrMD @verhemel @Rjnuis @JoostDaemen @drnvanmieghem
Lim Yinghao retweeted
A new echocardiographic algorithm provides accurate classification of left ventricular filling pressure, reducing indeterminate cases, particularly in patients with preserved ejection fraction. @SNagueh ahajournals.org/doi/full/10.…
Lim Yinghao retweeted
This comprehensive review by Goel et al. explores the principles, procedural details, and outcomes of techniques including BASILICA, ShortCut, UNICORN, and newer methods like CATHEDRAL and Splitter. Each approach is discussed in the context of anatomical challenges, device innovation, and operator experience. @GilbertTangMD
eurointervention.pcronline.c…
#TAVI #InterventionalCardiology #LeafletModification #StructuralHeart #ValveTherapy #EAPCI
Lim Yinghao retweeted
In another study published in #JACCINT, the timing of noncardiac surgery after #TAVR was not associated with increased perioperative risk, suggesting that surgical delays based solely on interval from TAVR may be unnecessary. jacc.org/doi/10.1016/j.jcin.… #vhdAS #cvSurg
When feasible, delaying noncardiac surgery, particularly beyond 100 days, appears to be associated with a reduction in adverse events, suggesting a potential opportunity for optimization of patient outcomes 💡 jacc.org/doi/10.1016/j.jacad…
#JACCAdvances #cvCABG #cvSurg @CoreLabUCLA
Lim Yinghao retweeted
#ClotWarriors rejoice! Hey it works for us! Mechanical #thrombectomy better than🩸thinning alone for intermediate risk #PulmonaryEmbolism in our cohort🇸🇬!
📍improved PASP, RV/LV ratio, TAPSE, TAPSE/PASP, ICU stay, total hospital days, 30D mortality
thrombosisresearch.com/artic…
Lim Yinghao retweeted
In this paper, @LeivaOrly, @SripalBangalore et al. reported that early catheter-based therapy (≤1 day) in intermediate-/high-risk PE significantly reduces 90-day mortality, readmissions, bleeding, and length of stay vs delayed therapy. lnkd.in/dxQwZ7d9 #PE #CBT #CDT #InterventionalCardiology
Lim Yinghao retweeted
Redo-TAVR for tall-frame valves:
(Navitor, Acurate, Evolut)
Real-world CT analysis led by @yusuke_kobari
Coronary Risk affected by:
🎯1st valve design
🎯 1st valve depth
🎯 2nd valve depth
Article 👇
@JACCJournals
sciencedirect.com/science/ar…
Lim Yinghao retweeted
UNICORN-assisted Redo-TAVR
⚠️ Sapien-in-Acurate
⛔️ High CO Risk
🛠️ Planning w/ Bench-testing
✅ Preserved coronary flow
Making the Unfeasible -> Feasible.
@RigsHeart @yusuke_kobari @YinghaoLim @YWillemen
Lim Yinghao retweeted
🌟 ACE Valve academy @RigsHeart 🇩🇰
Live cases, interactive discussions, and peer-to-peer learning on:
🎯 IVUS in TAVI
🎯 Coronary access techniques
🎯 Orbital Atherectomy
🎯 Trans-Axillary TAVI
🎯 Large annuli
And great fun with a great team 🙌
@YinghaoLim @yusuke_kobari
Lim Yinghao retweeted
Our first #Mitral #TEER #Pascal prior CABG patient, severe DMR, large prolapse P2-P1, flail segment P2/P1 junction. No residual MR with one #PascalACE. Echo POD 1 showed trivial MR, MG of 1mmHg. Thrilled with the result and grateful for the strong teamwork @NUHCS structural heart
Lim Yinghao retweeted
Trans-national tutorial over the South China Sea. Dr @YinghaoLim from NUHCS, Singapore gave an amazing tutorials on cardiac hemodynamics to Dr in Sarawak, Serdang and the Philippines! Teaching without boundaries!
Thanks Dr Joshua for organizing.
Aortic PVL closure with 8mm AVP4. 5 Fr guide wouldn’t track despite balloon assistance and anchorage. AVP4 delivered through a Cordis 4 Fr diagnostic
Lim Yinghao retweeted
AICT-AsiaPCR 2024 united over 800 clinical experts, healthcare professionals, researchers, & industry partners for an engaging knowledge exchange!
#NUHCS is proud to be Singapore’s only LIVE transmission centre, showcasing 3 educational cases to the global cardiology community.
Bioprosthetic mitral valve flail leaflet. Most impressive V wave I’ve seen - 74mmHg. Successful mVIV with Sapien3 26mm with Sentinel CEP
#mVIV #TMVR #structuralintervention #CardioTwitter
Echo before and 1 day after pulmonary thrombectomy. Dramatic patient and RV recovery - normalised RV size and function.
@InariMedical #flowtriever
#pulmonaryembolism #clotwarrior
Lim Yinghao retweeted
🚨NEW ARTICLE🚨
The assessment of left ventricular diastolic function: Guidance and recommendations from @BSEcho: ow.ly/iBab50S3QEo










































